Back to 
BROWN BROTHERS HARRIMAN & CO
BROWN BROTHERS HARRIMAN & CO
AMRX
Showing 0 of 2 quarters
Position history for BROWN BROTHERS HARRIMAN & CO's holdings in AMNEAL PHARMACEUTICALS INC
No. Brown Brothers Harriman exited its AMRX (Amneal Pharmaceuticals) position in Q4 2022. Its Q3 2022 13F listed 1,688 shares worth $3,000. Brown Brothers Harriman first reported AMRX in Q3 2022 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.